Co-organised by the British Toxicology Society and the American College of Toxicology
23-27 July 2018
The Møller Centre, Cambridge, United Kingdom
Early Bird Registration deadline: 1st June 2018
This highly acclaimed course will provide training in Toxicology as applied in Drug Development to scientists from all parts of the world. Participants will obtain an overall understanding of the principles of nonclinical safety evaluation with emphasis on the practical application of these principles and interpretation of nonclinical safety data. Regulatory toxicology in drug development will be emphasised, from both a European and a US perspective. Through the week the students will participate in tutored group study of regulatory cases and original data from a regulatory submission which will conclude with a half-day workshop.
The course is intended to benefit individuals from biotechnology and pharmaceutical companies working with either small or large molecules, along with those from CROs, regulatory agencies and academia who are interested in toxicology and its application in safety assessment of drugs and medical products and for toxicologists early in their career seeking more in-depth knowledge and understanding of the role of toxicology in safety assessment. It is also suitable for scientists trained in ancillary disciplines (such as chemistry, biochemistry, molecular biology, medicine, etc.) making a career change to work in drug safety assessment.
This course is recognized by EUROTOX as providing 32 hours of education for continuing professional development. It is approved by the Royal Society of Biology for purposes of CPD and may be counted as 32 CPD credits.
Further information & to register, please visit https://execbs.eventsair.com/patdd-2018/patdd2018